This track examines the intersection of modern science, policy-making, and business in the context of emerging technologies. It delves into how scientific advancements, particularly in AI and biotechnology, are influencing business practices and policy frameworks. Discussions will explore the implications of these technologies on innovation, regulatory challenges, and ethical considerations. The session aims to provide insights into how businesses can adapt to and leverage scientific progress to drive growth and sustainability in a rapidly evolving technological landscape.